Bactiguard has received a new order from Well Lead Medical (Well Lead) in China. The order will be delivered before the end of the year and generate revenues in the fourth quarter of approximately SEK 10 million.
In June 2018, Bactiguard signed a combined distribution and license agreement with Well Lead at an initial value of over 30 million. At the same time, the cooperation with former distributor Jian AN was terminated and Bactiguard paid a compensation of approximately SEK 11 million for their investments in the marketing and Chinese product approval process.
The agreement with Well Lead, China’s leading manufacturer of consumable medical devices, includes all products in Bactiguard’s portfolio and initially generates revenues of more than SEK 30 million in the form of product deliveries and license fees.
The first product order was of the same size as the new order and generated revenues of approximately SEK 10 million in the second quarter. In addition, the agreement with Well Lead has generated license revenues of just over SEK 8 million so far this year.
This information is information that Bactiguard Holding AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below 2018-12-21, at 14:15
For further infromation, please contact:
Cecilia Edström, CFO, cell phone: +46 722 262 328
